CC
PTLA

CQS Cayman’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

CQS Cayman’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-35,000
Closed -$1.33M – 230
2015
Q1 		$1.33M Sell
35,000
-15,000
-30% -$515K 0.06% 149
2014
Q4 		$1.42M Buy
+50,000
New +$1.39M 0.09% 115

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

CQS Cayman's PTLA Position: Q2 2015 in Review

CQS Cayman sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2015, closing a stake of 35,000 shares — an estimated $1.33M sold.

CQS Cayman first reported a position in PTLA in Q4 2014 and held it in 2 quarters. The position peaked at $1.42M in Q4 2014. 160 funds tracked by Wall St. Rank hold PTLA as of Q2 2015.

  • CQS Cayman reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • CQS Cayman sold 35,000 Portola Pharmaceuticals, Inc. shares in Q2 2015, an estimated $1.33M.
  • CQS Cayman first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 2 quarters.
  • CQS Cayman's Portola Pharmaceuticals, Inc. position peaked at $1.42M in Q4 2014.
  • 160 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2015.

Based on CQS Cayman's 13F filing for Q2 2015, filed 12 Aug 2015.